Kazuhisa Takahashi
Teikyo University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kazuhisa Takahashi.
Rheumatology | 2011
Tomonori Shigemura; Junichi Nakamura; Shunji Kishida; Yoshitada Harada; Seiji Ohtori; Koya Kamikawa; Nobuyasu Ochiai; Kazuhisa Takahashi
OBJECTIVESnThe purpose of this study was to clarify the incidence of (CS)-associated osteonecrosis among different underlying diseases and to evaluate the risk factors for steroid-associated osteonecrosis in a prospective MRI study.nnnMETHODSnWe prospectively used MRI to study 337 eligible underlying disease patients requiring CS therapy and succeeded in examining 1199 joints (hips and knees) in 302 patients with MRI for at least 1 year starting immediately after the onset of CS therapy (1-year follow-up rate of 90%). The underlying diseases included SLE in 687 joints (173 patients) and a variety of other rheumatological disorders in 512 joints (129 patients).nnnRESULTSnThe incidence of osteonecrosis was significantly higher in SLE patients than in non-SLE patients (37 vs 21%, Pu2009=u20090.001). Logistic regression analysis revealed that adolescent and adult patients had a significantly higher risk of osteonecrosis compared with paediatric patients [odds ratio (OR)u2009=u200913.2], that high daily CS dosage (>40u2009mg/day) entailed a significantly higher risk of osteonecrosis compared with the dosage of <40u2009mg/day (ORu2009=u20094.2), that SLE patients had a significantly higher risk of osteonecrosis compared with non-SLE patients (ORu2009=u20092.6) and that male patients had a significantly higher risk of osteonecrosis compared with female patients (ORu2009=u20091.6).nnnCONCLUSIONnThese findings suggest that the incidence of CS-associated osteonecrosis varies among different underlying diseases.
Spine Surgery and Related Research | 2017
Tsutomu Akazawa; Toshiaki Kotani; Tsuyoshi Sakuma; Shohei Minami; Sumihisa Orita; Kazuki Fujimoto; Yasuhiro Shiga; Masashi Takaso; Gen Inoue; Masayuki Miyagi; Yasuchika Aoki; Hisateru Niki; Yoshiaki Torii; Shigeta Morioka; Seiji Ohtori; Kazuhisa Takahashi
Introduction The purpose of this study was to investigate the long-term incidence of lumbar disc degeneration and Modic changes in the non-fused segments of patients with adolescent idiopathic scoliosis (AIS) who previously underwent spinal fusion. Methods Study subjects consisted of 252 patients with AIS who underwent spinal fusion between 1968 and 1988. Of 252 patients, 35 subjects underwent lumbar spine MRI and whole spine X-ray examination. The mean patient age at the time of follow-up was 49.8 years, with an average follow-up period of 35.1 years. We classified the subjects into two groups based on the lowest fused vertebra: H group whose lowest fused vertebra was L3 or higher levels and L group whose lowest fused vertebra was L4 or lower levels. Results The L group had significantly advanced disc degeneration on MRI. There was no significant difference between two groups in Modic changes. The L group showed less lumbar lordosis than the H group (H group: 48.1 degrees; and L group: 32.1 degrees) and greater SVA (H group: 1.2 cm; and L group: 5.5 cm). Conclusions In AIS patients, 35 years after spinal fusion surgery on average, we evaluated lumbar disc degeneration and Modic changes of the non-fused segments. In patients with the lowest fusion level at L4 or lower, there were reduced lumbar lordosis, considerable SVA imbalance, and severe disc degeneration compared with those with the lowest fusion level at L3 or higher. The lowest fusion level at L3 or higher is recommended to reduce disc degeneration in midlife.
Spine Surgery and Related Research | 2017
Sumihisa Orita; Kazuhide Inage; Miyako Suzuki; Kazuki Fujimoto; Kazuyo Yamauchi; Junichi Nakamura; Yusuke Matsuura; Takeo Furuya; Masao Koda; Kazuhisa Takahashi; Seiji Ohtori
Introduction Osteoporosis is a pathological state with an unbalanced bone metabolism mainly caused by accelerated osteoporotic osteoclast activity due to a postmenopausal estrogen deficiency, and it causes some kinds of pain, which can be divided into two types: traumatic pain due to a fragility fracture from impaired rigidity, and pain derived from an osteoporotic pathology without evidence of fracture. We aimed to review the concepts of osteoporosis-related pain and its management. Methods We reviewed clinical and basic articles on osteoporosis-related pain, especially with a focus on the mechanism of pain derived from an osteoporotic pathology (i.e., osteoporotic pain) and its pharmacological treatment. Results Osteoporosis-related pain tends to be robust and acute if it is due to fracture or collapse, whereas pathology-related osteoporotic pain is vague and dull. Non-traumatic osteoporotic pain can originate from an undetectable microfracture or structural change such as muscle fatigue in kyphotic patients. Furthermore, basic studies have shown that the osteoporotic state itself is related to pain or hyperalgesia with increased pain-related neuropeptide expression or acid-sensing channels in the local tissue and nervous system. Traditional treatment for osteoporotic pain potentially prevents possible fracture-induced pain by increasing bone mineral density and affecting related mediators such as osteoclasts and osteoblasts. The most common agent for osteoporotic pain management is a bisphosphonate. Other non-osteoporotic analgesic agents such as celecoxib have also been reported to have a suppressive effect on osteoporotic pain. Conclusions Osteoporotic pain has traumatic and non-traumatic factors. Anti-osteoporotic treatments are effective for osteoporotic pain, as they improve bone structure and the condition of the pain-related sensory nervous system. Physicians should always consider these matters when choosing a treatment strategy that would best benefit patients with osteoporotic pain.
Spine Surgery and Related Research | 2017
Yasuhiro Shiga; Sumihisa Orita; Kazuhide Inage; Jun Sato; Kazuki Fujimoto; Hirohito Kanamoto; Koki Abe; Go Kubota; Kazuyo Yamauchi; Yawara Eguchi; Masahiro Inoue; Hideyuki Kinoshita; Yasuchika Aoki; Junichi Nakamura; Yusuke Matsuura; Richard A. Hynes; Takeo Furuya; Masao Koda; Kazuhisa Takahashi; Seiji Ohtori
Introduction Oblique lateral interbody fusion (OLIF) can achieve recovery of lumbar lordosis (LL) in minimally invasive manner. The current study aimed to evaluate the location of lateral intervertebral cages during OLIF in terms of LL correction. Methods The subjects were patients who underwent OLIF for lumbar degenerative diseases, including lumbar spinal stenosis, spondylolisthesis, and discogenic low back pain. Their clinical outcome was evaluated using visual analogue scale on lower back pain (LBP), leg pain and numbness. The following parameters were retrospectively evaluated on plain radiographic images and computed tomography scans before and at 1 year after OLIF: the intervertebral height, vertebral translation, and sagittal angle. The cage position was defined by equally dividing the caudal endplate into five zones (I to V), and its association with segmental lordosis restoration was analyzed. Subjects were also evaluated for a postoperative endplate injury. Results Eighty patients (121 fused levels) with lumbar degeneration who underwent OLIF were included. There were no significant specific distribution in preoperative disc pathology such as disc angle, height, and translation. After OLIF, sagittal alignment was improved with an average correction angle of 3.8º at the instrumented segments in a level-independent fashion. All cases showed significant improvement in clinical outcomes, and had improvement in the radiological parameters (P<0.05). A detailed analysis of the cage position showed that the most significant sagittal correction and the most postoperative endplate injuries occurred in the farthest anterior zone (I). Cages with a 12-mm height were associated with more endplate injuries compared with shorter cages (8 or 10 mm). Conclusions OLIF improves sagittal alignment with an average correction angle of 3.8º at the instrumented segments. We suggest that the optimal cage position for better lordosis correction and the fewest endplate injuries is zone II with a cage height of up to 10 mm.
千葉医学雑誌 | 2008
Hiroshi Tamai; Masahiko Suzuki; Yoshikazu Tsuneizumi; Tadashi Tsukeoka; A Banks Scott; Hideshige Moriya; Kazuhisa Takahashi
Archive | 2007
Yasuchika Aoki; Kazuhisa Takahashi; Seiji Ohtori; Hideshige Moriya
Spine Surgery and Related Research | 2018
Sumihisa Orita; Miyako Suzuki; Kazuhide Inage; Yasuhiro Shiga; Kazuki Fujimoto; Hirohito Kanamoto; Koki Abe; Masahiro Inoue; Hideyuki Kinoshita; Masaki Norimoto; Tomotaka Umimura; Kazuyo Yamauchi; Yasuchika Aoki; Junichi Nakamura; Yusuke Matsuura; Shigeo Hagiwara; Yawara Eguchi; Tsutomu Akazawa; Kazuhisa Takahashi; Takeo Furuya; Masao Koda; Seiji Ohtori
CHIBA MEDICAL JOURNAL Open Access Paper = 千葉医学雑誌 | 2017
Junichi Nakamura; Nobuyasu Ochiai; Seiji Ohtori; Sumihisa Orita; Shigeo Hagiwara; Hironori Yamazaki; Takane Suzuki; Kazuhisa Takahashi
千葉医学雑誌 = Chiba medical journal | 2016
Takane Suzuki; Kazuki Kuniyoshi; Yusuke Matsuura; Rei Abe; Hitoshi Kiuchi; Keisuke Ueno; Tomoyo Akasaka; Aya Kanazuka; Maki Iwase; Naoya Hirosawa; Jin Takahashi; Jun Kakizaki; Toshikazu Kunishi; Kenichi Murakami; Kouji Sukegawa; Nahoko Iwakura; Kazuhisa Takahashi
CHIBA MEDICAL JOURNAL Open Access Paper = 千葉医学雑誌 | 2016
Takanori Omae; Junichi Nakamura; Seiji Ohtori; Sumihisa Orita; Takane Suzuki; Miyako Suzuki; Shuichi Miyamoto; Shigeo Hagiwara; Takayuki Nakajima; Makoto Takazawa; Tomonori Shigemura; Yasushi Wako; Michiaki Miura; Yuya Kawarai; Masahiko Sugano; Kento Nawata; Kazuhisa Takahashi